Shanghai Haohai Biological Technology Co., Ltd. (688366.SS)
CNY 61.2
(2.02%)
CNY 61.2
(2.02%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -2.33 Billion CNY | 3.77% |
| 2022 | -2.42 Billion CNY | 13.3% |
| 2021 | -2.79 Billion CNY | 6.34% |
| 2020 | -2.98 Billion CNY | 5.93% |
| 2019 | -3.17 Billion CNY | -126.35% |
| 2018 | -1.4 Billion CNY | 20.35% |
| 2017 | -1.75 Billion CNY | 11.28% |
| 2016 | -1.98 Billion CNY | 8.92% |
| 2015 | -2.17 Billion CNY | -1100.93% |
| 2014 | -181.34 Million CNY | 8.01% |
| 2013 | -197.13 Million CNY | -22.59% |
| 2012 | -160.81 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -2.2 Billion CNY | 1.84% |
| 2024 Q1 | -2.25 Billion CNY | 3.24% |
| 2024 Q2 | -2.24 Billion CNY | 0.64% |
| 2023 Q3 | -2.37 Billion CNY | 8.48% |
| 2023 FY | -2.33 Billion CNY | 3.77% |
| 2023 Q4 | -2.33 Billion CNY | 1.94% |
| 2023 Q2 | -2.59 Billion CNY | -8.11% |
| 2023 Q1 | -2.4 Billion CNY | 0.79% |
| 2022 Q1 | -2.63 Billion CNY | 5.63% |
| 2022 FY | -2.42 Billion CNY | 13.3% |
| 2022 Q4 | -2.42 Billion CNY | 3.2% |
| 2022 Q3 | -2.5 Billion CNY | 8.02% |
| 2022 Q2 | -2.72 Billion CNY | -3.18% |
| 2021 Q4 | -2.79 Billion CNY | 0.64% |
| 2021 FY | -2.79 Billion CNY | 6.34% |
| 2021 Q3 | -2.81 Billion CNY | 8.39% |
| 2021 Q1 | -2.93 Billion CNY | 1.73% |
| 2021 Q2 | -3.07 Billion CNY | -4.7% |
| 2020 Q1 | 3.23 Billion CNY | 201.9% |
| 2020 FY | -2.98 Billion CNY | 5.93% |
| 2020 Q2 | -2.99 Billion CNY | -192.61% |
| 2020 Q4 | -2.98 Billion CNY | -2.57% |
| 2020 Q3 | -2.9 Billion CNY | 2.82% |
| 2019 Q1 | 1.45 Billion CNY | 204.09% |
| 2019 FY | -3.17 Billion CNY | -126.35% |
| 2019 Q2 | -1.45 Billion CNY | -199.63% |
| 2019 Q4 | -3.17 Billion CNY | 0.0% |
| 2018 Q1 | -1.34 Billion CNY | 23.59% |
| 2018 FY | -1.4 Billion CNY | 20.35% |
| 2018 Q4 | -1.4 Billion CNY | 0.0% |
| 2018 Q3 | -1.4 Billion CNY | -4.24% |
| 2018 Q2 | -1.34 Billion CNY | 0.0% |
| 2017 Q2 | -1.71 Billion CNY | -0.08% |
| 2017 FY | -1.75 Billion CNY | 11.28% |
| 2017 Q4 | -1.75 Billion CNY | 0.0% |
| 2017 Q3 | -1.75 Billion CNY | -2.74% |
| 2017 Q1 | -1.71 Billion CNY | 13.71% |
| 2016 FY | -1.98 Billion CNY | 8.92% |
| 2016 Q4 | -1.98 Billion CNY | 0.0% |
| 2016 Q2 | -2.16 Billion CNY | 0.0% |
| 2016 Q1 | -2.16 Billion CNY | 0.77% |
| 2016 Q3 | -1.98 Billion CNY | 8.21% |
| 2015 FY | -2.17 Billion CNY | -1100.93% |
| 2015 Q4 | -2.17 Billion CNY | 0.0% |
| 2015 Q3 | -2.17 Billion CNY | -298.57% |
| 2015 Q2 | -546.4 Million CNY | 0.0% |
| 2015 Q1 | -546.4 Million CNY | -201.31% |
| 2014 FY | -181.34 Million CNY | 8.01% |
| 2014 Q3 | -181.34 Million CNY | 8.71% |
| 2014 Q2 | -198.65 Million CNY | 0.0% |
| 2014 Q4 | -181.34 Million CNY | 0.0% |
| 2014 Q1 | -198.65 Million CNY | -0.77% |
| 2013 Q3 | -197.13 Million CNY | 0.0% |
| 2013 Q4 | -197.13 Million CNY | 0.0% |
| 2013 FY | -197.13 Million CNY | -22.59% |
| 2013 Q1 | 167.81 Million CNY | 0.0% |
| 2012 FY | -160.81 Million CNY | 0.0% |